BioSpecifics Technologies (BSTC) Tops Q1 EPS by 5c

BioSpecifics Technologies (NASDAQ: BSTC) reported Q1 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $2.8 million versus the consensus estimate of $2.46 million.

For earnings history and earnings-related data on BioSpecifics Technologies (BSTC) click here.

You May Also Be Interested In

• Lynx Equity on Sandisk: 'Strong buyer into investor confusion', Raises PT to $2,550
• Installed Building Products (IBP) Tops Q2 EPS by 36c
• Aemetis (AMTX) Tops Q2 EPS by 13c